OBIO Stock Earnings: Orchestra BioMed Hldgs Misses EPS, Beats Revenue for Q2 2024

    Date:

    Orchestra BioMed Hldgs (NASDAQ:OBIO) just reported results for the second quarter of 2024.

    • Orchestra BioMed Hldgs reported earnings per share of -45 cents. This was below the analyst estimate for EPS of -39 cents.
    • The company reported revenue of $778,000.
    • This was 3.73% better than the analyst estimate for revenue of $750,000.

    InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com.

    Chart

    SignUp For Breaking Alerts

    New Graphic

    We respect your email privacy

    Share post:

    Popular

    More like this
    Related

    Elon Musk Weighs In On MAGA Divide, Urges GOP To Purge ‘Contemptible Fools’

    In the midst of the ongoing infighting within the...

    Azerbaijan Airlines Flight Hit by ‘External Interference’ Over Russia Before Fatal Crash

    An Azerbaijan Airlines flight which crashed on Christmas Day...

    Warren Buffett’s Stock Market Advice: Ignore Neighbor’s Whispers On Stock Tips, Focus On Long-Term Value

    In an interview with Fortune in 2013, legendary investor...